New systemic therapies, including chemotherapy, electrochemotherapy, and immunotherapy (such as cemiplimab), and epidermal growth factor receptor inhibitors, are used for metastatic and locally advanced cSCC [2]. This evidence concerns the gene EGFR and skin squamous cell carcinoma.